AstraZeneca rises after it reportedly made $10 billion bid for obesity drugmaker Rhythm
AZN•AstraZeneca reportedly offered about $10 billion for Rhythm Pharmaceuticals, including up to $134 per share plus payments tied to milestone achievements. AstraZeneca shares rose 1.3%.
1. Reported bid
AstraZeneca made a non-binding offer of about $10 billion for obesity drugmaker Rhythm Pharmaceuticals, Reuters reported, citing people familiar with the matter. The proposal offered as much as $134 per share, including payments for milestone achievements.
